Abstract

Objective To study the clinical significance of Raynaud phenomenon (RP) in systemic lupus erythematosus(SLE).Methods One hundred and twelve cases with SLE were divided into two groups according to the condition of RP and were analyzed retrospectively.The similarities and differences were investigated in system injury and laboratory examination in two groups.Results The occurrence rates of pulmonary arterial hypertension (PAH),interstitial lung disease (ILD),pericarditis,fatigue,pulmonary embolism (PE) and deep venous thrombosis (DVT) in patients with RP were higher than those in patients without RP [89.3%(25/28) vs.2.4%(2/84),57.1%(16/28) vs.16.7%(14/84),75.0%(21/28) vs.39.3% (33/84),67.9%(19/28) vs.33.3%(28/84),21.4%(6/28) vs.4.8%(4/84),14.3%(14/28) vs.1.2%(1/84) ](P < 0.05 ).The positive rates of anti-cardiolipin (ACL) antibody,anti-RNP antibody,anti-Sm antibody and LA in patients with RP were higher than those in patients without RP [46.4%(13/28) vs.9.5%(8/84),75.0%(21/28) vs.33.3%(28/84),57.1%(16/28) vs.23.8%(20/84),17.9%(5/28) vs.2.4%(2/84)] (P <0.05),while leucopenia in patients with RP was lower than that in patients without RP [7.1%(2/28) vs.45.2% (38/84)] (P =0.001).Conclusion Heart,lung and vascular lesions such as PAH,ILD,pericarditis,PE and so on are easier to occur in SLE with RP,furthermore the positive rates of ACL,anti-RNP antibody,anti-Sm antibody,and LA are higher than those without RP. Key words: Lupus erythematosus, systemic; Hypertension, pulmonary; Raynaud disease

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.